Newly FDA-cleared blood tests are now making it easier for doctors to diagnose Alzheimer’s disease.
FDA-cleared blood tests are streamlining Alzheimer’s diagnosis while a new study suggests a single blood biomarker might predict symptom onset age.
Why it mattersFDA-cleared blood biomarkers for Alzheimer's enable clinicians to target earlier trial enrollment and care planning.